EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetes‐induced vascular calcification is associated with low pyrophosphate and its oral supplementation prevents calcification in diabetic mice

Krisztina Fülöp, Eszter Kozák, Natália Tőkési, Lilian Kocsis, Anikó Kelemen, Zsuzsanna Geszti, Adriána Kutás, Mariann Harangi, Ágnes Diószegi, Zsolt Rapi, József Balla, Olivier Le Saux und 2 weitere

FEBS Open Bio · 2026-03 · 16 (3) · 474-486

DOI: 10.1002/2211-5463.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 13.10.2025. Verfasst von Krisztina Fülöp und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Life Sciences, Research Centre for Natural Sciences, Centre of Excellence of the Hungarian Academy of Sciences, HUN-REN, Budap…. Hauptthemen laut MEDLINE: Vascular Calcification, Diphosphates, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Research, Development and Innovation Office of Hungary, Hungarian Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The predominant cause of death among diabetic patients comes from cardiovascular complications, including vascular calcification. The objectives of this study were to improve the understanding of the molecular mechanisms involved in diabetes‐related calcification and to test potential preventive therapies. We found that levels of plasma pyrophosphate—a potent inhibitor of calcification—were decreased in type 1 and type 2 diabetic patients with cardiovascular symptoms. To further investigate vascular calcification, we developed a diabetic mouse model that showed increased aorta and renal calcification compared to control. Alkaline phosphatase activity was also increased in the circulation of diabetic mice, which resulted in a significant decrease in plasma pyrophosphate. Oral treatment with pyrophosphate prevented diabetes‐induced calcification in mice, providing a direct translational value for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular CalcificationDiphosphatesDiabetes Mellitus, ExperimentalAnimalsMiceMaleHumansAdministration, OralMice, Inbred C57BLDiabetes Mellitus, Type 2Disease Models, AnimalDietary SupplementsAlkaline PhosphataseFemaleDiabetes Mellitus, Type 1

Stichwörter der Autor:innen

cardiovascular calcificationdiabetesmouse modelpyrophosphate

Substanzen

Diphosphatesdiphosphoric acidAlkaline Phosphatase

Autor:innen und Institutionen

  • Institute of Molecular Life Sciences, Research Centre for Natural Sciences, Centre of Excellence of the Hungarian Academy of Sciences, HUN-REN, Budapest, Hungary.
  • Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Vascular Pathophysiology Research Group 11003, University of Debrecen, HUN-REN, Debrecen, Hungary.
  • Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Budapest, Hungary.
  • Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.

ORCID-Profile: Viola Pomozi

Förderung

  • NIH HHS
  • National Research, Development and Innovation Office of Hungary
  • Hungarian Research Network
  • National Institutes of Health
  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal

Zitieren

APA

Fülöp, K., Kozák, E., Tőkési, N., Kocsis, L., Kelemen, A., Geszti, Z., Kutás, A., Harangi, M., Diószegi, Á., Rapi, Z., Balla, J., Le Saux, O., Váradi, A., & Pomozi, V. (2026). Diabetes‐induced vascular calcification is associated with low pyrophosphate and its oral supplementation prevents calcification in diabetic mice. FEBS Open Bio, 16(3), 474-486. https://doi.org/10.1002/2211-5463.70141

Vancouver

Fülöp K, Kozák E, Tőkési N, Kocsis L, Kelemen A, Geszti Z, et al. Diabetes‐induced vascular calcification is associated with low pyrophosphate and its oral supplementation prevents calcification in diabetic mice. FEBS Open Bio. 2026;16(3):474-486. doi:10.1002/2211-5463.70141

BibTeX
@article{Flp2026,
  author = {Fülöp, Krisztina and Kozák, Eszter and Tőkési, Natália and Kocsis, Lilian and Kelemen, Anikó and Geszti, Zsuzsanna and Kutás, Adriána and Harangi, Mariann and Diószegi, Ágnes and Rapi, Zsolt and Balla, József and Le Saux, Olivier and Váradi, András and Pomozi, Viola},
  title = {Diabetes‐induced vascular calcification is associated with low pyrophosphate and its oral supplementation prevents calcification in diabetic mice},
  journal = {FEBS Open Bio},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {474--486},
  doi = {10.1002/2211-5463.70141}
}
Kostenlos starten →